carbostyril has been researched along with Pancreatic Insufficiency in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Akshintala, VS; Cebotaru, L; Cutting, GR; Dezube, R; Faghih, M; Jennings, MT; Kamal, A; Lechtzin, N; Merlo, CA; Singh, VK; West, NE; Whitcomb, DC | 1 |
Mulrennan, S; Popowicz, N; Vekaria, S; White, SW | 1 |
Carr, SB; Davies, JC; Jones, D; Nichols, AL | 1 |
Akong, K; Lim, M; Munce, D | 1 |
Aitken, ML; Carter, S; Durfey, S; Grogan, B; Hayden, HS; Hoffman, LR; McKone, EF; McNamara, S; Nay, L; Parsek, MR; Pope, CE; Ratjen, A; Rosenfeld, MR; Singh, PK; Vo, AT; Weiss, EJ | 1 |
Fajac, I; Wainwright, CE | 1 |
Champion, E; Gopalareddy, V; Goralski, JL; Megalaa, R | 1 |
Hamilton, JL; Robson, J; Zobell, JT | 1 |
2 review(s) available for carbostyril and Pancreatic Insufficiency
Article | Year |
---|---|
Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor.
Topics: Adolescent; Age Factors; Aminophenols; Carrier Proteins; Chloride Channel Agonists; Cystic Fibrosis; Duration of Therapy; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficiency; Feces; Female; Humans; Pancreatic Elastase; Quinolones; Recovery of Function | 2020 |
New treatments targeting the basic defects in cystic fibrosis.
Topics: Adolescent; Adult; Aminophenols; Child; Child, Preschool; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Exocrine Pancreatic Insufficiency; Genetic Therapy; Humans; Infant; Infant, Newborn; Interdisciplinary Communication; Intersectoral Collaboration; Life Expectancy; Phenotype; Prognosis; Quinolones; Young Adult | 2017 |
6 other study(ies) available for carbostyril and Pancreatic Insufficiency
Article | Year |
---|---|
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis.
Topics: Adult; Aged; Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Female; Humans; Indoles; Male; Middle Aged; Quinolones; Retrospective Studies | 2019 |
To be or not to be on CFTR modulators during pregnancy: Risks to be considered.
Topics: Adult; Aminophenols; Bronchiectasis; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Delivery, Obstetric; Drug Dosage Calculations; Exocrine Pancreatic Insufficiency; Female; Gestational Age; Humans; Infant, Newborn; Lung Diseases; Monitoring, Physiologic; Mutation; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pseudomonas; Quinolones | 2020 |
Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor.
Topics: Aminophenols; Child; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Female; Humans; Male; Mutation; Pancreas; Quinolones | 2020 |
Changes in fecal microbiota with CFTR modulator therapy: A pilot study.
Topics: Adolescent; Adult; Aminophenols; Anti-Bacterial Agents; Child; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Feces; Humans; Microbiota; Pilot Projects; Quinolones; Young Adult | 2021 |
Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use.
Topics: Aminophenols; Child; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Humans; Male; Quinolones; Treatment Outcome | 2019 |
Pancreatic insufficiency converted to pancreatic sufficiency with ivacaftor.
Topics: Aminophenols; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Humans; Quinolones | 2019 |